Search
Calcimycin
go.drugbank.com/drugs/DB19408InvestigationalPrimarily used as a biochemical tool for studying divalent cations in biological systems, Calcimycin also exhibits antibiotic activity against gram-positive bacteria and fungi.
Aprobarbital
go.drugbank.com/drugs/DB01352ExperimentalIllicitA primary treatment indicated for the use of aprobarbital was subsequently insomnia.
Xanthine
go.drugbank.com/drugs/DB02134InvestigationalThe methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. (Dorland, 28th ed)
Tamuzimod
go.drugbank.com/drugs/DB21621InvestigationalTamuzimod is under investigation in clinical trial NCT05156125 (VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis).
Bimokalner
go.drugbank.com/drugs/DB21717InvestigationalBimokalner is under investigation in clinical trial NCT06521190 (ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin).
Tarenflurbil
go.drugbank.com/drugs/DB05289InvestigationalIn June 2008 development of the drug for Alzheimer's disease was discontinued. Tarenflurbil has also been used in trials studying the treatment of Prostate Cancer.
CERE-110
go.drugbank.com/drugs/DB05898InvestigationalCERE-110 is a gene-therapy product that involves in vivo delivery of nerve growth factor (NGF) genes through an adeno-associated viral vector (AAV) delivery system. This drug is developed by Ceregene and currently under phase I of clinic...
ARC183
go.drugbank.com/drugs/DB05124ExperimentalThe key advantage of ARC183 compared to other thrombin inhibitors is its rapid onset of action and short half-life, giving it the potential to be an ideal agent for medical procedures that require rapid
Emetonium iodide
go.drugbank.com/drugs/DB13769ExperimentalCategories: Drugs for Functional Gastrointestinal Disorders